Markers of MC disease including levels of serum tryptase, percentage KIT D816V, percentage MCs in BM, hepatosplenomegaly, and diagnosis of osteopenia/porosis did not differ significantly between the drug and placebo arms. This evidence concerns the gene KIT and Osteopenia.